EARNINGS: Origin Enterprises beats operating profit target
22nd Sep 2026 18:21
(Alliance News) - The following is a round-up of earnings reports by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 203.00p on 09-10-2026 at 18:35:06 |
|---|---|
| Change | 1.00p 0.5% |
| Buy | 206.00p |
| Sell | 200.00p |
| Last Trade: | Sell 160,000.00 at 198.28125p |
| Day's Volume: | 853,304 |
| Last Close: | 203.00p |
| Open: | 202.00p |
| ISIN: | GB00BJQTGV64 |
| Day's Range | 201.00p - 203.50p |
| 52wk Range: | 126.00p - 205.00p |
| Market Capitalisation: | £172.49m |
| VWAP: | 201.00271p |
| Shares in Issue: | 84.97m |
Sector: Health Care and Related Services
Listed In: FTSE AIM All-Share,
Diaceutics (DXRX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 160,000 | 198.28125p | Negotiated Trade |
16:45:00 - 09-Oct-26 |
| Buy* | 532 | 205.60p | Ordinary |
16:17:00 - 09-Oct-26 |
| Buy* | 10 | 206.00p | Ordinary |
15:47:37 - 09-Oct-26 |
| Sell* | 2,350 | 202.00p | SI Trade |
15:30:42 - 09-Oct-26 |
| Sell* | 2,350 | 202.00p | SI Trade |
15:30:42 - 09-Oct-26 |
| Sell* | 256 | 200.00p | SI Trade |
15:23:34 - 09-Oct-26 |
| Buy* | 12 | 206.00p | SI Trade |
15:23:34 - 09-Oct-26 |
| Sell* | 10 | 200.00p | SI Trade |
15:23:34 - 09-Oct-26 |
| Buy* | 10 | 206.00p | SI Trade |
15:23:34 - 09-Oct-26 |
| Buy* | 750 | 205.00p | Suspected BUY Trade |
15:23:13 - 09-Oct-26 |
Diaceutics (DXRX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 7th Oct 2026 7:10 am | RNS | Holding(s) in Company |
| 7th Oct 2026 7:00 am | RNS | Block Listing Return |
| 6th Oct 2026 7:00 am | RNS | PDMR Shareholding/SIP and Total Voting Rights |
| 24th Sep 2026 7:00 am | RNS-R | Diaceutics and Syndax expand Relay partnership |
| 22nd Sep 2026 7:00 am | RNS | Interim Results - six months ended 30 June 2026 |
| 8th Sep 2026 7:00 am | RNS | Notice of Results & Presentations |
| 2nd Sep 2026 3:08 pm | RNS | PDMR Shareholding/SIP & Total Voting Rights |
| 20th Aug 2026 8:00 am | RNS-R | Diaceutics and PCC launch NGS Concordance Study |
| 4th Aug 2026 2:00 pm | RNS | PDMR Shareholding/Share Incentive Plan & TVRs |
| 29th Jul 2026 7:00 am | RNS | 75% ARR Growth Drives Revenue & Profit Visibility |